NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Scre... (as co-founder CEO andpresident from 1997...)

NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test

Date:9/5/2007

as co-founder, CEO and president from 1997 to 2001. From 1994-1996, he served as president, CEO and a director of Trimeris Inc., a biopharmaceutical Company. From 1983 to 1994, Franco held several senior positions and served on the Executive Committee of Glaxo, Inc. He has served on the Board of Directors of lifescience companies Tranzyme, TriPath Imaging and EntreMed, Inc. He is currently a director of Salix Pharmaceuticals, Ltd., and the Research Triangle Chapter of the National Association of Corporate Directors (NACD). Franco holds a bachelor's degree in Pharmacy from St. John's University and has completed graduate work in pharmaceutical marketing and management at Long Island University.

About HALO(TM) Breast Pap Test

Drawing on the proven success of screening for the cellular and biological changes that signal an increased risk of developing prostate and cervical cancer, the HALO Breast Pap system collects Nipple Aspirate Fluid (NAF) using gentle suction like a breast pump. The screening occurs in the primary care setting, such as the ob-gyn, family practice, or internist office, where most women present for well-woman healthcare. A large body of clinical research demonstrates that the cytological assessment of Nipple Aspirate Fluid, or NAF, can identify a woman's relative risk of developing breast cancer. The presence in NAF of a known biomarker, Atypical Ductal Hyperplasia (ADH), confers a 400-500 percent greater risk of developing breast cancer than women who do not produce fluid.

About NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix(C) develops innovative devices that allow women and their Ob-Gyns to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast disease screening device designed for use in the Ob-Gyn office. The System has been FDA cleared for the collection of nipple aspirate fluid for cytological evaluation for the determination a
'/>"/>

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:

NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Scre...(as co-founder CEO andpresident from 1997...)